Ranbaxy Labs will market a drug for depression under an agreement with another company, the drug maker said Tuesday.
Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.
Generic drug maker Watson Pharmaceuticals is challenging the patent protection on an antidepressant made by Pfizer, the company said.
A major depressive disorder treatment made by Pfizer significantly reduced the number and severity of moderate-to-severe hot flashes in postmenopausal women, compared with placebo, according to a new study.
A new Consumer Reports health survey found that nearly 80% of respondents seeking treatment for...